Literature DB >> 23856759

Detection of aac(6')-Ib-cr in avian pathogenic Escherichia coli isolates in Japan.

Michiko Kawanishi1, Manao Ozawa, Mototaka Hiki, Hitoshi Abo, Akemi Kojima, Tetsuo Asai.   

Abstract

We investigated the prevalence of plasmid-mediated quinolone resistance (PMQR) genes in avian pathogenic Escherichia coli (APEC) strains in Japan. A total of 117 APEC strains collected between 2004 and 2007 were examined for PMQR genes (qnrA, qnrB, qnrC, qnrD, qnrS, aac(6')-Ib-cr, qepA and oqxAB) by polymerase chain reaction. None of the APEC strains carried qnrA, qnrB, qnrC, qnrD, qnrS, qepA or oqxAB, but one of the isolates was identified as an AAC (6')-Ib-cr producer. Phylogenetic grouping, multi-locus sequence typing and serotyping showed that this isolate belonged to phylogenetic group A, sequence type 167 and untypable serogroup. To our knowledge, this is the first report of the aac (6')-Ib-cr gene in bacteria from food-producing animals in Japan.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23856759      PMCID: PMC3942989          DOI: 10.1292/jvms.13-0185

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


Avian pathogenic Escherichia coli (APEC), the etiological agent of colibacillosis, causes local or systemic infections including colisepticemia, coligranuloma, air sac disease, pericarditis and swollen head syndrome [9]. Colibacillosis is responsible for large economic losses in the poultry industry throughout the world. In Japan, about 2,500,000 chickens were condemned with APEC by poultry meat inspection in 2011 according to a government report [17]. Of fluoroquinolone drugs, enrofloxacin (ERFX) was first approved for avian colibacillosis in 1991; subsequently, ofloxacin (OFLX), danofloxacin (DNFX) and norfloxacin (NFLX) were approved in Japan. Previously, resistance to all quinolones in Enterobacteriaceae was believed to be chromosome-encoded, i.e., amino acid substitution of DNA gyrase and topoisomerase IV (multiple mutations in the quinolone resistance-determining region), decreased outer membrane permeability (porin defect) or activation of naturally occurring efflux pumps [12]. In addition, the plasmid-mediated quinolone resistance (PMQR) genes, qnr, aac(6’)-Ib-cr, qep and oqx, have been reported in bacteria isolated from humans and food-producing animals worldwide [24]. In Japan, qnrS1 was first identified in human isolates of Shigella flexneri in 2003 [11]. Clinical isolates of E. coli harboring qepA and oqxAB were found in 2002 and 2008, respectively [23, 29]. In addition, qnrS1 has been detected in Salmonella isolated from food-producing animals [1, 3]. In these reports, the source of PMQR genes in Enterobacteriaceae in Japan is described. APEC strains are considered to be one of the most exposed to fluoroquinolones among the pathogenic bacteria in food-producing animals based on the sales of volume of broilers and the period of approval of the antibiotics. The aim of this work was to assess the prevalence of PMQR genes in APEC strains in Japan and characterize the PMQR-gene-positive strain. A total of 117 APEC strains were collected from chickens with colibacillosis (one isolate per chicken) between 2004 and 2007 in Japan. Isolates obtained between 2004 and 2006 were reported in our previous study [2, 19]. The presence of the qnrA, qnrB and qnrS genes was determined by polymerase chain reaction (PCR) [5]. The qnrC and qnrD genes were detected using previously described primers [6, 27]. The qepA, oqxAB and aac(6’)-Ib genes were detected as previously described [7, 16, 20]. Of the 117 APEC isolates, two isolates (18-PLEc-C-36 collected in 2006 and 19-PLEc-C-53 collected in 2007) were positive for aac(6’)-Ib, and none of the isolates was positive for the other PMQR genes. AAC(6’)-Ib-cr differs from AAC(6’)-Ib by two amino acids, Trp102Arg and Asp179Tyr, and these substitutions allow it to reduce the antibacterial activities of not only aminoglycoside but also NFLX and ciprofloxacin through acetylation of their piperazinyl substituent [26]. The aac(6’)-Ib gene sequences were determined by direct sequencing of the PCR products from the two positive isolates. The aac(6’)-Ib gene from18-PLEc-C-36 showed complete identity to the aac(6’)-Ib-cr gene from a strain of Klebsiella pneumoniae (GenBank accession number EU195449), while the 19-PLEc-C-53 sequence was identified as wild-type aac(6’)-Ib (accession number AF322577). We next confirmed the production of the fluoroquinolone-modifying enzyme AAC(6’)-Ib-cr in 18-PLEc-C-36 strain using a disk-based method reported by Wachino [26]. Briefly, the 18-PLEc-C-36 strain was grown in LB broth (Becton, Dickinson and Co., Sparks, MD, U.S.A.) containing NFLX (8mg/l) with shaking for 18 hr at 35°C. The broth containing the same concentration of NFLX in the other tube was used as the control. Fifty microliters of each culture medium was applied on the blank disk set on a Mueller-Hinton agar (Becton, Dickinson and Co.) plate inoculated with E. coli ATCC 25922 and incubated for 18 hr at 35°C. The growth-inhibitory zone of the 18-PLEc-C-36 culture medium significantly decreased compared with the control. Sequence typing and virulence gene detection were then investigated in 18-PLEc-C-36 strain. The following 12 virulence genes were detected by PCR, as described previously: afa/draBC, papA, papC, sfaS and focG(adhesins); cnf1 and hlyA(toxins); iutA(siderophore); neuC(KI antigen); tsh(autotransporter); cvaC(colicin V) and iss(increased serum survival) [8, 14, 18]. Absence of four virulence genes (papC, tsh, cvaC and iss) of 18-PLEc-C-36 strain was already reported [19]. ST was determined using the MLST database (http://mlst.ucc.ie/mlst/dbs/Ecoli*) [28]. In addition, bacterial conjugation was performed using 18-PLEc-C-36 strain as the donor strain and E. coli DH5α (rifampicin and nalidixic acid (NA) resistance) as the recipient, using broth mating method. Plasmids were extracted from 18-PLEc-C-36 strain and the transconjugant using Qiagen mini-kit (Qiagen, Gaithersburg, MD, U.S.A.) according to the manufacturer’s instructions. Plasmid incompatibility grouping was performed using the transconjugant and a PCR-based replicon typing method [4]. 18-PLEc-C-36 strain was resistant to ampicillin (ABPC), cefazoline (CEZ), kanamycin (KM), oxytetracycline (OTC) and fluoroquinolone drugs (ERFX, DNFX, NFLX and OFLX) (Table 1) [2, 19]. Therefore, the susceptibility of 18-PLEc-C-36 transconjugant for ABPC, CEZ, KM, OTC, ERFX, DNFX, NFLX and OFLX was determined by the same method [2, 19]. The transconjugant was resistant to ABPC (MIC, 128mg/l) and CEZ (MIC, 64 mg/l), but susceptible to KM (MIC, ≤4 mg/l), OTC (MIC, 1 mg/l), ERFX (MIC, 0.125 mg/l), DNFX (MIC, 0.25 mg/l), NFLX (MIC, 0.5 mg/l) and OFLX (MIC, 0.25 mg/l). MICs of the transconjugant for fluoroquinolone drugs including NFLX were the same with those of the recipient. 18-PLEc-C-36-transconjugant was aac(6’)-Ib-cr and blaCTX-M-15 positive by PCR and had an approximately 48-kbp plasmid. The transconjugant belonged to Inc.FI incompatibility group.
Table1.

Characteristics of aac (6’)-Ib-cr-positive strain, 18-PLEc-C-36

STphylogenetictypea)serogroupa)β-lactamasea)virulence gene
Antimicrobial susceptibilitya)
afa/draBCiutAother virulence genesb)MIC for fluoroquinolones (mg/l)
Resistance type
ERFXDNFXNFLXOFLX
ST167group AuntypableCTX-M-15++12825612864ABPC-CEZ-KM-OTC-NA-ERFX-DNFX-NFLX-OFLX

a) Previously reported by Asai et al. or Ozawa et al. [2, 19]. b) Other virurences were: papA, sfaS, focG, cnf1, hlyA and neuC. Absence of papC, tsh, cvaC and iss in 18-PLEc-C-36 was previously reported by Ozawa et al. [19].

a) Previously reported by Asai et al. or Ozawa et al. [2, 19]. b) Other virurences were: papA, sfaS, focG, cnf1, hlyA and neuC. Absence of papC, tsh, cvaC and iss in 18-PLEc-C-36 was previously reported by Ozawa et al. [19]. The characteristics of aac(6’)-Ib-cr positive strain are summarized in Table 1. It was reported that a specific genotype of fluoroquinolone-resistant O78 APEC may be widely distributed and that 80% of APEC strains have the iss virulence gene, and more than half of those have tsh and cva in Japan [19]. The characteristics of the AAC(6’)-Ib-cr producer are different from those of predominant fluoroquinolone-resistant APEC strains already reported in Japan. In human clinical field, the serotype O25b-ST131-B2 clone harboring both blaCTX-M-15 and aac(6’)-Ib-cr has spread worldwide, however, there are no reports of the ST167 clone harboring both these genes. The complete sequence of the pEK499 plasmid (strain A: 117536bp) from one O25b-ST131-B2 isolate has been reported and appears to be a fusion of type FII and FIA replicons, harbored resistance genes blaCTX-M-15, blaOXA-1, blaTEM-1, aac(6’)-Ib-cr, mph (A), catB4 and tet (A). These were responsible for cephalosporin, β-lactamase inhibitor, aminoglycoside, chloramphenicol and tetracycline resistance. And, FII replicon and multireplicons FIA, FIB and FII have been described in blaCTX-M-15-carrying plasmids of ST131 E. coli [22]. The size, plasmid replicon type and antimicrobial resistance patterns differed between O25b-ST131-B2 and 18-PLEc-C-36. With regard to ST167, clonal relatedness was identified between a Mongolian avian extended-spectrum β-lactamase (blaCTX-M-9) producing E. coli isolate and a clinical isolate that originated from a hospitalized patient in Europe [10]. Since aac(6’)-Ib-cr was first detected in clinical isolates in China in 2000, it has been found in clinical Enterobacteriaceae isolates worldwide including in Japan [21, 26]. Isolates harboring aac(6’)-Ib-cr have also been detected in food-producing animals in Korea, China and Europe [7, 15, 16, 25]. Particularly in China, a clear trend of increase in the prevalence of aac(6’)-Ib-cr among the isolates from chicken was observed from 2001 to 2007 [13]. In contrast, this is the first report of an isolate harboring aac(6’)-Ib-cr from food-producing animals in Japan. Furthermore, qnrA, qnrB, qnrC, qnrD, qnrS, qepA and oqxAB were not detected in any of the APEC isolates in this study. To date, no PMQR genes other than qnrS1 have been detected in food-producing animals in Japan [1, 3], suggesting a low prevalence of PMQR in this country. In conclusion, an aac(6’)-Ib-cr positive isolate was first detected from food-producing animal in Japan. The characters, serotype, phylogenetic type, virulence-associated gene and ST of isolate are different from those of predominant fluoroquinolone-resistant APEC in Japan and of E. coli harboring aac(6’)-Ib-cr and blaCTX-M-15 previously reported in human and animal. Although PMQR genes confer only low-level resistance, they spread horizontally and facilitate the selection of additional chromosome-encoded quinolone resistance mechanisms [21]. In addition, PMQR is frequently found in the isolates from food-producing animals in the world, and it would be difficult to prevent the invasion of resistance genes from foreign countries to Japan [13]. Continuous monitoring of PMQR in food-producing animals is essential to assess the risk of transmitting fluoroquinolone-resistant bacteria and resistance determinants to humans.
  28 in total

1.  A fluoroquinolone-resistant Escherichia coli clinical isolate without quinolone resistance-determining region mutations found in Japan.

Authors:  Toyotaka Sato; Shin-ichi Yokota; Ikuo Uchida; Torahiko Okubo; Kanako Ishihara; Nobuhiro Fujii; Yutaka Tamura
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

2.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

Review 3.  The worldwide emergence of plasmid-mediated quinolone resistance.

Authors:  Ari Robicsek; George A Jacoby; David C Hooper
Journal:  Lancet Infect Dis       Date:  2006-10       Impact factor: 25.071

4.  Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.

Authors:  J R Johnson; A L Stell
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

5.  International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries.

Authors:  Kees Veldman; Lina M Cavaco; Dik Mevius; Antonio Battisti; Alessia Franco; Nadine Botteldoorn; Mireille Bruneau; Agnès Perrin-Guyomard; Tomas Cerny; Cristina De Frutos Escobar; Beatriz Guerra; Andreas Schroeter; Montserrat Gutierrez; Katie Hopkins; Anna-Liisa Myllyniemi; Marianne Sunde; Dariusz Wasyl; Frank M Aarestrup
Journal:  J Antimicrob Chemother       Date:  2011-03-09       Impact factor: 5.790

Review 6.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Antimicrobial susceptibilities, serogroups, and molecular characterization of avian pathogenic Escherichia coli isolates in Japan.

Authors:  Manao Ozawa; Kazuki Harada; Akemi Kojima; Tetsuo Asai; Toshiya Sameshima
Journal:  Avian Dis       Date:  2008-09       Impact factor: 1.577

8.  qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.

Authors:  L M Cavaco; H Hasman; S Xia; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

9.  Epidemiology of plasmid-mediated quinolone resistance in salmonella enterica serovar typhimurium isolates from food-producing animals in Japan.

Authors:  Tetsuo Asai; Chizuru Sato; Kaori Masani; Masaru Usui; Manao Ozawa; Tomoe Ogino; Hiroshi Aoki; Takuo Sawada; Hidemasa Izumiya; Haruo Watanabe
Journal:  Gut Pathog       Date:  2010-12-07       Impact factor: 4.181

10.  Comparable high rates of extended-spectrum-beta-lactamase-producing Escherichia coli in birds of prey from Germany and Mongolia.

Authors:  Sebastian Guenther; Katja Aschenbrenner; Ivonne Stamm; Astrid Bethe; Torsten Semmler; Annegret Stubbe; Michael Stubbe; Nyamsuren Batsajkhan; Youri Glupczynski; Lothar H Wieler; Christa Ewers
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  1 in total

1.  Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolated from diseased animals in Taiwan.

Authors:  Jih-Ching Yeh; Dan-Yuan Lo; Shao-Kuang Chang; Chi-Chung Chou; Hung-Chih Kuo
Journal:  J Vet Med Sci       Date:  2017-03-02       Impact factor: 1.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.